The U.S. Food and Drug Administration’s (“FDA” or “the Agency”) Center for Devices and Radiological Health (“CDRH”) recently announced the launch of its Total Product Life Cycle Advisory Program (“TAP”) Pilot. The first phase...more
As part of the U.S. government’s response to the COVID-19 pandemic, on March 10, 2020, the Secretary of Health and Human Services (“Secretary”) issued a Declaration pursuant to the Public Readiness and Emergency Preparedness...more
4/22/2020
/ Coronavirus/COVID-19 ,
Countermeasures ,
Covered Entities ,
Distributors ,
Immunity ,
Manufacturers ,
Medical Devices ,
Pharmaceutical Industry ,
Property Damage ,
Public Health ,
Public Readiness and Emergency Preparedness Act (PREP Act)